Loading company…
Ruijian Biotech develops drugs and research platforms for neurological conditions.
Founded in 2019 and based in Shenzhen, Ruijian Biotech develops psychotropic drugs and research platforms for neurological medicines. Its pipelines include treatments for resistant depression, drug addiction, and PTSD, as well as a non-opioid analgesic designed to cross the blood-brain barrier. The company reported completing a financing round as of 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in